SLC5A2 and hydrops fetalis: Whether vericiguat would have a more pronounced positive effect on ventricular remodeling if added to optimal HF therapy including sacubitril/valsartan and SGLT2 inhibitors, and in a more specific group, with less unstable patients, are questions that merit to be addressed in future studies [127,128,129].